Advisory Committee on Immunization Practices Recommends PREVNAR 20® (20-Valent Pneumococcal Conjugate Vaccine) for Adults Aged 50 and Older

Amgen Gears Up to Report Q3 Earnings: Here's What to Expect

Starboard Slams Pfizer for R&D Inefficiencies, Overpaid Acquisitions

FDA expands Pfizer’s RSV vaccine label to include all high-risk adults

PFE Gets FDA Nod for Expanded Use of RSV Vaccine Abrysvo

FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years

Analysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for

Should You Buy, Sell or Hold Pfizer Stock Before Q3 Earnings?

Pfizer, Lilly pressed about telehealth prescriber relationships, STAT reports

Is Pfizer Stock A Sell After Starboard Fires Shots In Its Battle With Management?

Pfizer’s RSV vaccine cleared by FDA for use in some younger adults

Gold, Bitcoin, and Bond Yields Are Rising. Why That’s Not Bad for Stocks and 5 Other Things to Know Today.